TGFB1 and chronic obstructive pulmonary disease: Main results show that, compared with controls, COPD patients present: (1) reduced surface expression of CD44, a key macrophage efferocytosis receptor; and, (2) similar lung tissue levels of TGFβ, VEGF, and HGF, despite the presence of more inflammation and tissue damage.